Summary
We report a population-based study of patterns of care and survival for people with acute leukaemia diagnosed at age 15–29 years during 1984–94 in regions of England and Wales covered by specialist leukaemia registries. There were 879 patients: 417 with acute lymphoblastic leukaemia (ALL) and 462 with acute myeloid leukaemia (AML). For ALL, actuarial survival rates were 43% at 5 years after diagnosis and 37% at 10 years. Survival improved significantly between 1984–88 and 1989–94 for those aged 15–19 at diagnosis. Patients entered in national clinical trials and those not entered had similar survival rates. Survival rates were similar at teaching and non-teaching hospitals and at hospitals treating different numbers of study patients per year. For AML, survival rates were 42% at 5 years after diagnosis and 39% at 10 years. Survival improved significantly between 1984–88 and 1989–94. Patients entered in the Medical Research Council AML10 trial had a higher survival rate than those who were in the earlier AML9 trial. Survival did not vary with category of hospital. We conclude that survival has improved for adolescents and young adults with acute leukaemia but that there is at present no evidence that centralized treatment results in a survival benefit for patients in this age group.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Badrinath, P., Day, N. E. & Stockton, D. (1997). Population-based survival trends for leukaemia in East Anglia, United Kingdom. J Publ Health Med 19: 403–407.
Benjamin, S., Cartwright, R. A., Clough, J. V., Gorst, D. W., Proctor, S., Ross, J. R. Y., Stiller, C., Wheatley, K. & Whittaker, J. A. (1997). Haematologists’ approaches to the management of young adults with acute leukaemia (abstract). Br J Haematol 97: (suppl. 1) 56
Cartwright, R. A., McNally, R. J. Q., Rowland, D. J., Thomas, J., Gilman, E., Gorst, D., Morgan, G., Prentice, A., Staines, A. & Stiller, C. (1997). The Descriptive Epidemiology of Leukaemia and Related Conditions in Parts of the United Kingdom 1984–93, Leukaemia Research Fund: London
Charlton, B. G., Taylor, P. R. A. & Proctor, S. J. (1997). The PACE (population-adjusted clinical epidemiology) strategy: a new approach to multi-centre clinical research. Q J Med 90: 147–151.
Chessells, J. M., Hall, E., Prentice, H. G., Durrant, J., Bailey, C. C. & Richards, S. M. (1998). The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties. Leukemia 12: 463–473.
Durrant, I. J. & Richards, S. M. (1993). Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults; report from the Medical Research Council Working Party on adult leukaemia. Br J Haematol 85: 84–92.
Durrant, I. J., Prentice, H. G. & Richards, S. M. (1997). Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Br J Haematol 99: 84–92.
Evensen, S. A., Brinch, L., Tjonnford, G., Stavem, P. & Wisloff, F. (1994). Estimated 8-year survival of more than 40% in a population-based study of 79 adult patients with acute lymphoblastic leukaemia. Br J Haematol 88: 88–93.
Expert Advisory Group on Cancer (1995). A Policy Framework for Commissioning Cancer Services (Calman and Hine Report), Department of Health: London
Goldstone, A. H., Lazarus, H. M., Franklin, I. M., Richards, S., Anderson, J. W. & Rowe, J. M. (1997). Bone marrow transplantation versus chemotherapy in acute lymphoblastic leukaemia. Joint trial of the Medical Research Council (UKALL-12) with the United States Eastern Cooperative Oncology Group E2993. Haematol Blood Trans 38: 700–703.
Gorst, D. W. & Johnson, K. W. (1992). Survival in adult leukaemia. Clin Lab Haematol 14: 99–108.
Hann, I. M., Stevens, R. F., Goldstone, A. H., Rees, J. K. H., Wheatley, K., Gray, R. G. & Burnett, A. K. (1997). Randomised comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukaemia. Results of the Medical Research Council’s 10th AML trial (MRC AML10). Blood 89: 2311–2318.
Haward, R. A. (1995). Establishing cancer units. Br J Cancer 72: 531–534.
Kerr, D. J., Griffiths, R. & Edwards, B. (1996). Delivering cancer care: a model from the West Midlands. Br J Cancer 74: 667–669.
Marcus, R. E., Catovsky, D., Prentice, H. G., Newland, A. C., Chessells, J. M., Stevens, R. F., Hann, I. M., Goldman, J. M., Hoffbrand, A. V. & Galton, D. A. (1987). Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML). Joint AML trial 1982–85. Haematol Blood Trans 30: 346–351.
Nachman, J., Sather, H. N., Buckley, J. D., Gaynon, P. S., Steinherz, P. G., Tubergen, D. G., Lampkin, B. C. & Hammond, G. D. (1993). Young adults 16–21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukaemia and acute myeloblastic leukaemia protocols. Results of treatment. Cancer 71: 3377–3385.
Proctor, S. J. (1994). Acute lymphoblastic leukaemia in adults: the case for a strategic shift in study approach. Br J Haematol 88: 229–233.
Proctor, S. J., Taylor, P., Thompson, R. B., Finney, R., Reid, M. M., Hamilton, P. J., Saunders, P., Fail, B., Dickinson, A., Paul, B., Qureshi, M., Tinegate, H., Lennard, A., Stainsby, D., Goff, D., Kay, L., Cartner, R., Mamood, A., Bird, T., Condie, P., Collins, A., Abela, M., Renwick, L., Walker, W. & Evans, R. G. B. (1985). Acute lymphoblastic leukaemia in adults in the Northern Region of England – a study of 75 cases. Q J Med 57: 761–774.
Proctor, S. J., Taylor, P. R. A., Stark, A., Carey, P. J., Bown, N., Hamilton, P. J. & Reid, M. M. (1995). Evaluation of the impact of allogeneic transplant in first remission on an unselected population of patients with acute myeloid leukaemia aged 15–55 years. Leukemia 9: 1246–1251.
Rees, J. K. H., Gray, R. G. & Wheatley, K. (1996). Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council’s AML 9 study. Br J Haematol 94: 89–98.
Secker-Walker, L. M., Prentice, H. G., Durrant, J., Richards, S., Hall, E. & Harrison, G. (1997). Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. Br J Haematol 96: 601–610.
Selby, P., Gillis, C. & Haward, R. (1996). Benefits from specialised cancer care. Lancet 348: 313–318.
Souhami, R. L., Whelan, J., McCarthy, J. F. & Kilby, A. (1996). Benefits and problems of an adolescent oncology unit. In Cancer and the Adolescent, Selby P and Bailey C (eds), pp. 276–283, BMJ: London
Stiller, C. A. (1994a). Population based survival rates for childhood cancer in Britain, 1980–91. BMJ 309: 1612–1616.
Stiller, C. A. (1994b). Centralised treatment, entry to trials and survival. Br J Cancer 70: 352–362.
Stiller, C. A. & Draper, G. J. (1989). Treatment centre size, entry to trials and survival in acute lymphoblastic leukaemia. Arch Dis Child 64: 657–661.
Stiller, C. A. & Eatock, E. M. (1994). Survival from acute non-lymphocytic leukaemia, 1971–88: a population-based study. Arch Dis Child 70: 219–223.
Taylor, I. (1996). Problems of site specific cancer specialisation. BMJ 313: 1213
Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyms, R., Andreeff, M., Tafuri, A., Jakubowski, A., Gabrilove, J., Gordon, M. S. & Dmitrovsky, E. (1991). Differentiation therapy of acute promyelocytic leukaemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324: 1385–1393.
Youngson, JHAM, Jones, J. M., Chang, J. G., Harris, M. & Banergee, S. S. (1995). Treatment and survival of lymphoid malignancy in the north-west of England: a population-based study. Br J Cancer 72: 757–765.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Stiller, C., Benjamin, S., Cartwright, R. et al. Patterns of care and survival for adolescents and young adults with acute leukaemia – a population-based study. Br J Cancer 79, 658–665 (1999). https://doi.org/10.1038/sj.bjc.6690104
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690104
Keywords
This article is cited by
-
DKG-Zertifizierung kinderonkologischer Zentren – ein weites Feld …
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2020)
-
Access to principal treatment centres and survival rates for children and young people with cancer in Yorkshire, UK
BMC Cancer (2017)
-
Barriers and facilitators for clinical trial participation among diverse Asian patients with breast cancer: a qualitative study
BMC Women's Health (2016)
-
Effect of the type of treatment facility on the outcome of acute myeloid leukemia in adolescents and young adults
Leukemia (2016)
-
Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children’s Cancer Study Group (TCCSG) clinical trials
International Journal of Hematology (2014)
